Market Overview:
Antimicrobial Susceptibility Testing Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.4% during the forecast period (2022-2029).
Antimicrobial susceptibility testing out is a laboratory technique performed via scientific technologists or scientific laboratory scientists to determine which antimicrobial routine is in particular efficacious for man or woman sufferers. On an massive scale, it enables compare remedy services brought by way of hospitals, clinics, and national applications for managing and stopping infectious sicknesses.
To Download free sample @ Click Here
Market Dynamics
The growing want for antimicrobial susceptibility checking out across the globe drives the marketplace boom
Antimicrobial resistance has seemed as a chief chance to public fitness international. According to the World Health Organization, antibiotic resistance is growing to dangerously high tiers in all areas of the world, leading to better morbidity and mortality.
In addition, the World Bank estimates that drug-resistant infections ought to set off a worldwide economic crisis, main to 28 million those who may be moved into excessive poverty each yr by means of 2050, with an universal fee to the worldwide financial system of USD 1 trillion in line with 12 months.
Exact and brief detection of resistance to antimicrobial pills and following suitable antimicrobial remedy, incorporated with antimicrobial stewardship, are essential for controlling the emergence and unfold of AMR. The first-rate healing option for treating bacterial infections relies on the consequences of AST, part of the habitual work of all scientific microbiological laboratories. Reports offer an information of nearby antimicrobial susceptibility patterns, assisting healthcare specialists pick the most effective antibiotic therapy. For example, if the AMR rate of a pathogen is above 20%, that drug ought to now not be administered as a unmarried empiric therapy for contamination remedy.
In addition, the market gamers are adopting the marketplace strategies together with acquisition and product launches. For example, in April 2022, BIOMÉRIEUX agreed to collect Specific Diagnostics. This privately held U.S.-primarily based enterprise has advanced a fast antimicrobial susceptibility test, SPECIFIC REVEAL Rapid AST gadget that supplies phenotypic AST directly from high quality blood cultures.
Moreover, in February 2020, Bio-Rad Laboratories, Inc. Acquired Exact Diagnostics, a developer and producer of diagnostic products that help make sure the validity and consistency of test consequences. With the acquisition of Exact Diagnostics, Bio-Rad Laboratories, Inc. Has access to a complete catalog of molecular fine control merchandise in transplant, breathing, virology, microbiology, sexually transmitted infections, and vector-borne diseases.
Market Segmentation:
By Product Type
- Manual Antimicrobial Susceptibility Testing Products
- Automated Laboratory Instruments
- Consumables
By Method
- Broth Dilution Method
- Rapid Automated Method
- Disk Diffusion Method
- Gradient Diffusion Method
By Test Type
- Antibacterial
- Antifungal
- Antiparasitics
By Application
- Clinical Diagnosis
- Drug Discovery and Development
- Others
By End User
- Diagnostic Centers and Hospitals
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Research and Academic Institutes
Competitive Landscape
The antimicrobial susceptibility testing market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market’s growth are bioMérieux S.A., Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck Group, HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, and Synbiosis, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global antimicrobial susceptibility testing market.
For instance, In October 2021, Thermo Fisher Scientific and Q-linea launched ASTar Technology, a quick antimicrobial susceptibility testing (AST) system that provides true minimum inhibitory concentration (MIC) data in less than 6 hours. Conventional AST techniques might take up to 72 hours to obtain findings.
Trending Topics:
Arthropod borne Viral Infections Testing Market
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/antimicrobial-susceptibility-testing-market